Interestingly, recent evidence suggests that phosphorylation of EZH2 by AKT at S21 site leads to PRC2-independent association of EZH2 with androgen receptor and activation of its target genes in prostate cancer cells (Xu et al., 2012). Here, EZH2 is linked to prostate cancer.